Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Kiniksa Pharmaceuticals International (KNSA) Return on Assets (2021 - 2025)

Kiniksa Pharmaceuticals International (KNSA) has disclosed Return on Assets for 5 consecutive years, with 0.09% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Assets rose 16.0% year-over-year to 0.09%, compared with a TTM value of 0.09% through Dec 2025, up 16.0%, and an annual FY2025 reading of 0.1%, up 17.0% over the prior year.
  • Return on Assets was 0.09% for Q4 2025 at Kiniksa Pharmaceuticals International, up from 0.06% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.5% in Q2 2023 and bottomed at 0.68% in Q4 2021.
  • Average Return on Assets over 5 years is 0.03%, with a median of 0.09% recorded in 2024.
  • The sharpest move saw Return on Assets surged 108bps in 2022, then tumbled -42bps in 2023.
  • Year by year, Return on Assets stood at 0.68% in 2021, then soared by 158bps to 0.4% in 2022, then tumbled by -65bps to 0.14% in 2023, then crashed by -144bps to 0.06% in 2024, then surged by 252bps to 0.09% in 2025.
  • Business Quant data shows Return on Assets for KNSA at 0.09% in Q4 2025, 0.06% in Q3 2025, and 0.02% in Q2 2025.